FY24Q1 concall notes
-
ATBS (40% of sales; 170 cr.)
o Destocking from oil & gas customers as they had overstocked earlier (accounts for 30% of ATBS sales). Expect demand to normalize starting October 2023 as end demand has not been impacted
o 90% decline was due to volume and 10% due to price realizations
o Expansion from 40k to 60k tons will commercialize in March 2024. Expansion is based on confirmed orders from repeat customers
o Have not seen competition from any Indian manufacturer (Atvantic Finechem) -
Anti-oxidants and butyl phenols (Veeral additives; 17% of sales):
o Commercial ramp-up was slower, will do 150 cr. in FY24 and double in FY25
o Currently operating at 25% utilization
o Doubly backward integrated with butyl phenol and isobutylene
o Doing R&D into more niche AOs (higher realization, lower volume)
o Total revenue potential from butyl phenols and antioxidants will be 900-1000 cr. with 15-20% EBITDA margin (butyl phenol ~300 cr. + AOs ~600 cr.) - IBB (20% of sales; 86 cr.): Expected to remain steady in FY24. One Indian producer exited market this quarter
-
Veeral Organics:
o 260 cr. capex for MEHQ, Guaiacol, Iso Amylene derivatives and Anisoles. These products were used in polymerization inhibitors, flavors, fragrances, pharmaceuticals, and pesticides
o Total capacity for Anisole will be 5000 MTPA; for MEHQ and Guaiacol combined capacity will be 3000 MTPA
o Potential revenues of 350 cr.
o Plant will be commissioned by March 2024
o Production by phenol route: from methanol and phenol you make Anisole and from Anisole you make MEHQ and Guaiacol. This is the most cost-effective route currently
o Other routes to manufacture MEHQ are based on hydroquinone which is a more expensive raw material than Anisole -
Power costs
o Commissioned 15 MW solar power plant, which is currently catering to 55% of electrical consumption.
o Adding 11 MW solar plant, to be commissioned by September 2023 - Custom manufacturing revenues: 150-175 cr. in FY24
Disclosure: Not invested (no transactions in last-30 days)
Subscribe To Our Free Newsletter |